Success Stories: EB-1A Petition Approved by Texas Service Center for a Postdoctoral Research Associate from India in the Field of Computational Chemistry

 

Client’s Testimonial:

"Wonderful experience. Will definitely recommend to my friends. Thank you for your help and support.”


On November 2nd, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Computational Chemistry (Approval Notice).


General Field: Computational Chemistry

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: India

Country of Residence at the Time of Filing: India

Approval Notice Date: November 2nd, 2020

Processing Time: 3 months and 20 days (Premium Processing requested)


Case Summary:

North America Immigration Law Group recently had the pleasure to work with a postdoctoral research associate from India. Our client hired us to help him file an I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category, which we did efficiently and effectively. Just 4 months after we filed the case, our client received an approval notice from the Texas Service Center.

EB-1A Petition Dossier:

Part of our legal services entailed helping our client narrow down a list of experts in his field of computational chemistry. We asked our client to approach the shortlisted experts and request for recommendation letters. Five of these specialists obliged and their testimonials played a big role in convincing the USCIS that our client’s petition deserved to be approved. One of our client’s recommenders described our client’s work as “His findings enable the acceleration of substrate transport and mechanical functions of membrane transporters, which till his study remained unknown. With these discoveries, [client’s] work has indisputably furthered the field of computational chemistry” A second expert wrote, “[Client] is a leading researcher in the study of membrane transporter proteins in particular. These proteins are a key factor in the successful absorption and processing of drug-based treatments, thus conferring indisputable value to the American pharmaceutical industry.”

Besides third party support, we also documented elements of our client’s professional portfolio. We noted the 363 citations to his work, the 6 times he conducted peer reviews, and his 16 peer-reviewed scientific articles, 1 book chapter, and 1 patent application. Most importantly, we carefully reviewed and detailed our client’s various research ventures on molecular dynamics and drug discovery. His research addresses some of our nation’s most pressing issues, including chronic disease and the development of more potent drugs with fewer adverse side effects.

Favorable Conclusion:

This EB-1A petition approval allows our client to partake in the final portion of the green card process: the I-485 application. Once this is approved, he will be welcomed into the country as an official United States permanent resident. We wish him well with this and thank him for selecting us to represent his EB1A case.